RINVOQ vs RINVOQ LQ
Independent side-by-side comparison.
Rating
72/100
72/100
Pharmacy pays
—
—
Type
RX
RX
Active ingredient
UPADACITINIB
UPADACITINIB
Dosage forms
Solution, Tablet, extended release
Solution
Drug class
Janus Kinase Inhibitor
Janus Kinase Inhibitor
Boxed warning
Half-life
about 8 to 14 hours (mean terminal elimination half-life)
about 8 to 14 hours (mean terminal elimination half-life)
Treats
Rheumatoid Arthritis
Rheumatoid Arthritis
Frequently asked questions
Which is better-rated, Rinvoq or Rinvoq Lq?
Rinvoq and Rinvoq Lq are tied at 3.6 out of 5 by our independent rating.
What is the difference between Rinvoq and Rinvoq Lq?
Both Rinvoq and Rinvoq Lq share the active ingredient Upadacitinib.
Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.